Hyaluronidase enhances the therapeutic effect of vinblastine in intralesional treatment of Kaposi's sarcoma

Journal of the American Academy of Dermatology

Volumn 36, Issue 2, 1997, Pages 239-242

  Smith, K J ^a   Skelton, H G ^a   Turiansky, G ^a   Wagner, K F ^a  

^a ARMED FORCES INSTITUTE OF PATHOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIDASE; VINBLASTINE;

ADULT; ARTICLE; BLISTER; CLINICAL ARTICLE; DRUG DIFFUSION; DRUG EFFICACY; DRUG SCREENING; HUMAN; HYPERPIGMENTATION; INTRALESIONAL DRUG ADMINISTRATION; KAPOSI SARCOMA; MALE; PRIORITY JOURNAL;

EID: 0031048011     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(97)70288-3     Document Type: Article

References (26)

1. AA Boudreaux LL Smith CD Cosby Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome J Am Acad Dermatol 28 1993 61 65
2. RB Odom DK. Goette Treatment of Kaposi's sarcoma with intralesional vincristine Arch Dermatol 114 1978 1693 1694
3. JB Epstein C. Scully Clinical features and treatment of thirty-three homosexual men with Kaposi's sarcoma Oral Surg Oral Med Oral Pathol 71 1991 38 41
4. JW Tappero MA Conant SF Wolfe Kaposi's sarcoma J Am Acad Dermatol 28 1993 371 395
5. A. Blalock Recent advances in surgery Surgery 4 1953 917 941
6. RT Dorr DS. Alberts Vinca alkaloid skin toxicity: antidote and drug disposition studies in the mouse J Natl Cancer Inst 74 1985 113 120
7. EA Elam RT Dorr KE Lagel Cutaneous ulceration due to contrast extravasation: experimental assessment of injury and potential antidotes Invest Radiol 26 1991 13 16
8. K Hobarth U Maier M. Marberger Topical chemoprophylaxis of superficial bladder cancer with mitromycin C and adjuvant hyaluronidase Eur Urol 21 1992 206 210
9. K Beckenlehner S Bannke T Sprub Hyaluronidase enhances the activity of adriamycin in breast cancer models in vitro and in vivo Cancer Res Clin Oncol 118 1992 591 596
10. P Bertrand N Girard B Delpech Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: comparison between invasive and non-invasive areas Int J Cancer 52 1992 1 6
11. M Decker ES Chiu C Dolbaum Hyaluronic acid–stimulating activity in sera from the bovine fetus and from breast cancer patients 49 1989 3499 3505 Can Res
12. E Ruoslahti EG Hayman MD. Pierschbacher Extracellular matrices and cell adhesion Arteriosclerosis 5 1985 581 593
13. EA. Turley Hyaluronan and cell locomotion Cancer Metastasis Rev 11 1992 21 30
14. NS Adizick MT. Longaker Scarless fetal healing: therapeutic implications Ann Surg 215 1992 3 7
15. BA Mast LC Flood JH Haynes Hyaluronic acid is a major component of the matrix of fetal rabbit skin and wounds: implication for healing by regeneration Matrix 11 1991 63 68
16. D Foschi L Castoldi E Radaelli Hyaluronic acid prevents oxygen free-radical damage to granulation tissue: a study in rats Int J Tissue Reactions 6 1990 333 339
17. KJ Smith HG Skelton J Yeager Cutaneous neoplasms in a military population of HIV-1–positive patients J Am Acad Dermatol 29 1993 400 406
18. DI. Abrams Acquired immunodeficiency syndrome and related malignancies: a topical overview Semin Oncol 18 1991 41 45
19. LM Evans LM Itri M Champion Interferon-alpha2a in the treatment of acquired immunodeficiency syndrome–related Kaposi's sarcoma J Immunother 10 1991 39 50
20. PA. Volberding The role of chemotherapy for epidemic Kaposi's sarcoma Semin Oncol 14 1987 23 26
21. RT. Mitsuyasu AIDS-related Kaposi's sarcoma: a review of its pathogenesis and treatment Blood Rev 2 1988 222 231
22. DW Northfelt JO Kahn PA Volberding Treatment of AIDS-related Kaposi's sarcoma Hematol Oncol Clin North Am 5 1991 297 309
23. JW Tappero TG Berger LD Kaplan Cyrotherapy for cutaneous Kaposi's sarcoma (KS) associated with acquired immune deficiency syndrome (AIDS): a phase II trial J Aquir Immune Defic Syndr 4 1991 839 846
24. E Sulis C Folris ML Sulis Interferon administered intralesionally in skin and oral cavity in heterosexual drug-addicted patients with AIDS-related Kaposi's sarcoma Eur J Cancer Clin Oncol 25 1989 759 761
25. B Tschechne P von Wussow I Schedel High-dose intralesional recombinant interferon-alpha-IIb treatment in HIV-1-infected patients with Kaposi's sarcoma Proceedings of the Sixth International Conference on AIDS, San Francisco June 20-24, 1990 abstract B210
26. J Dupuy M Price G Lynch Intralesional interferon-α and zidovudine in epidemic Kaposi's sarcoma J Am Acad Dermatol 28 1993 966 972